Notícias
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.
104last 24h
3124last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Motley Fool1d agobullish
Bristol Myers Squibb vs. Vertex: Which Pharma Stock Is a Better Buy for 2027?MT Newswires5d agobullish
UBS Adjusts Price Target on Vertex Pharmaceuticals to $640 From $615, Maintains Buy RatingMT Newswires5d agobullish
RBC Raises Price Target on Vertex Pharmaceuticals to $600 From $576, Keeps Outperform RatingInvestor's Business Daily6d agobullish
Vertex Continues Its Buy-Zone Run After Hiking 2026 Sales GuidanceInvestor's Business Daily47d agobullish
The Surprise That Sent Vertex - And Its Chief Rival - SoaringStocktwits47d agobullish
Twin Moves: VRTX Rises On Kidney Disease Trial Results, MAZE Rallies HarderInvestor's Business Daily52d agobullish
Gene-Editing Powerhouse And Its Rivals Surge Toward A BreakoutBarrons.com54d agobullish
Why Vera Therapeutics Stock Is Jumping on New Kidney Drug Trial ResultsMotley Fool55d agobullish
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool58d agobullish
Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in SeptemberMotley Fool65d agobullish
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?Motley Fool67d agobullish
2 Reasons CRISPR Therapeutics Stock Could Soar in the Final 4 Months of 2026